IceCure Participates in Society of Breast Imaging Symposium 2026 as U.S. ProSense® Revenue Increases by 30%+ in First Quarter of 2026 Compared to First Quarter of 2025

Go back to IceCure Participates in Society of Breast Imaging Symposium 2026 as U.S. ProSense® Revenue Increases by 30%+ in First Quarter of 2026 Compared to First Quarter of 2025
(NASDAQ: ICCM) Delayed: 6.12 +0.19 (3.20%)
Previous Close $5.93    52 Week High
Open $6.56    52 Week Low
Day High $7.25    P/E N/A 
Day Low $5.70    EPS
Volume 9,028,293